The goal of the NIH Summit on Anti-SARS-CoV-2 Antibodies for Treatment and Prevention of COVID-19: Lessons Learned and Remaining Questions is to summarize current knowledge and lessons learned on clinically relevant anti-SARS-CoV-2 antibodies for the treatment and/or prevention of COVID-19 and to identify key unanswered scientific questions to catalyze clinical development and implementation. The publicly broadcasted Summit will begin with opening remarks from NIH Director Dr. Francis S. Collins, Acting FDA Commissioner Dr. Janet Woodcock, and NIAID Director Dr. Anthony S. Fauci, followed by presentations on the current state of the science and three discussion sessions addressing the design, development and real world use of anti-SARS-CoV-2 antibodies.

Learn more here: